Sigyn Therapeutics SIGY Estimates

OTC SIGY
$0.03 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT
Analyst Estimates

Sigyn Therapeutics, Inc. Annual Revenue Estimates

Periods 4
Next Period 2017
Consensus 2.01 M

Analysts expect Sigyn Therapeutics, Inc. to report revenue of 2.01 M for 2017, against a range of 1.85 M to 2.18 M.

Metric 2017201820192020
Reported (Actual) --
High Estimate 2.18 M7.10 M
Low Estimate 1.85 M6.39 M
Consensus Estimate 2.01 M6.74 M
Analyst Estimates

Sigyn Therapeutics, Inc. Annual Earnings Per Share (EPS) Estimates

Periods 6
Next Period 2017
Consensus -444.31

Analysts expect Sigyn Therapeutics, Inc. to report earnings per share of -444.31 for 2017, against a range of -459.90 to -428.72.

Metric 201720182019202020212022
Reported (Actual) --
High Estimate -428.72-260.75
Low Estimate -459.90-298.03
Consensus Estimate -444.31-279.39